Denali Therapeutics
DNLI
#3955
Rank
S$2.99 B
Marketcap
$20.62
Share price
1.23%
Change (1 day)
1.42%
Change (1 year)

Earnings for Denali Therapeutics (DNLI)

Earnings in 2024 (TTM): -S$0.68 Billion

According to Denali Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -S$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Denali Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.67 Billion155.15%
2023 -S$0.26 Billion-42.27%
2022 -S$0.45 Billion15.21%
2021 -S$0.39 Billion-571.56%
2020 S$82.48 M-129.42%
2019 -S$0.29 Billion359.73%
2018 -S$60.99 Million-48.56%
2017 -S$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.16 Billion-75.93% Jersey
-S$0.21 Billion-68.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$16.29 Million-97.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$96.09 Million-85.44%๐Ÿ‡ฌ๐Ÿ‡ง UK